Equity Real Estate Investment Trusts (REITs)(IN00262.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Equity Real Estate Investment Trusts (REITs)
IN00262.US
News
View More

U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger

Wall Street analysts have updated their ratings and price targets for several U.S. companies. Notable changes include Equinix's target price raised to $1,050 by HSBC, KLA Corp receiving a sector perform rating with a target of $1,550 from RBC, and WW Grainger's target increased to $1,055. Other companies like Honeywell and Advanced Micro Devices also saw adjustments in their target prices. Overall, the report highlights various analysts' actions on U.S. stocks, reflecting a mix of upgrades and downgrades across the market.

Reuters·
US
GWW
+1.09%
US
KLAC
-0.51%
US
EQIX
-0.29%
Reuters·
US
GWW
+1.09%
US
KLAC
-0.51%
US
EQIX
-0.29%

01:24 ET FRMI Investors Have Opportunity to Lead Fermi Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm has filed a class action lawsuit against Fermi Inc. (NASDAQ: FRMI) for violations of federal securities laws. Investors who purchased Fermi's securities during the IPO period from October 1, 2025, to December 11, 2025, are encouraged to contact the firm by March 6, 2026. The lawsuit claims that Fermi made false statements regarding tenant demand and funding commitments for its Project Matador campus, leading to investor losses when the truth emerged. The class has not yet been certified, and potential claimants are advised to act promptly.

prnewswire·
US
FRMI
-5.82%
prnewswire·
US
FRMI
-5.82%

21:30 ET ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit

Rosen Law Firm has announced a class action lawsuit for investors who purchased securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024, and November 12, 2025. Investors may be entitled to compensation without upfront fees. The lawsuit claims misrepresentations regarding Ardent Health's accounts receivable and insufficient malpractice liability insurance. Interested investors can join the class action by contacting Phillip Kim, Esq. by March 9, 2026, to serve as lead plaintiff. No class has been certified yet, and investors can choose their counsel or remain absent.

prnewswire·
US
ARDT
-1.70%
prnewswire·
US
ARDT
-1.70%

J.P. Morgan Remains a Hold on Alexandria Equities (ARE)

J.P. Morgan analyst Anthony Paolone has maintained a Hold rating on Alexandria Equities (ARE) with a price target of $63.00. Paolone, a 3-star analyst with a 52.44% success rate, focuses on the Real Estate sector. Additionally, TipRanks reported that Anthropic also reiterated a Hold rating on the stock with a $54.00 price target.

Tip Ranks·
US
ARE
+2.75%
Tip Ranks·
US
ARE
+2.75%

U.S. stock movement update: BRC surged 35.94%, tech stocks active, Mereo Biopharma fell over 10%

In the past hour, the overall market in the US stock market has shown a clear divergence, with technology stocks and small-cap stocks performing relatively strongly, as funds seem to prefer high-growth stocks. In particular, the strong rise of BRC and 3 E Network Tech has attracted considerable attention from short-term funds, driving the activity in related sectors. Meanwhile, the pharmaceutical and real estate sectors appear to be relatively weak, with an increase in the number of stocks under pressure, reflecting fluctuations in market sentiment and a cautious attitude from investors. In the past hour, the stock with the largest movement, BRC, surged by 35.94%, attracting a large influx of funds in a short period, demonstrating strong market confidence in its future development. The strong performance of this stock not only boosted the enthusiasm in related industries but also sparked widespread attention from investors, with short-term sentiment running high. Strong stocks: 1. 3 E Network Tech: up 12.08%, recent technical breakthroughs have attracted many investors, with active short-term funds. 2. Borealis Foods: up 9.32%, market expectations for its future growth potential have increased, with noticeable fund inflows. 3. Sidus Space: up 8.53%, as the space industry heats up, this stock has gained favor among investors. 4. Biodexa Pharmaceuticals: up 8.13%, recent R&D progress has drawn market attention, with short-term funds actively involved

Tracking Unusual Activity·
US
WHLR
+1.75%
Tracking Unusual Activity·
US
WHLR
+1.75%
Posts
View More

Palantir CEO Alex Karp warns America is entering an AI “danger zone.”

While others chase demos, he’s focused on deployment, productivity, and putting AI into the hands of real workers.

$Palantir Tech(P...

Alex Karp warns some AI investments may not create enough value to justify the cost. That’s discipline.

In an AI gold rush, the real winners are the ones who care about returns, not just headlines. $Pa...

Bought SanDisk calls last week. Best decision ever!

© 2026 Longbridge｜Disclaimer